1. Home
  2. TSVT

as 06-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Founded: 2021 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 231.8M IPO Year: N/A
Target Price: $10.67 AVG Volume (30 days): 957.1K
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.35 EPS Growth: N/A
52 Week Low/High: $1.53 - $11.29 Next Earning Date: 05-08-2024
Revenue: $71,201,000 Revenue Growth: -42.90%
Revenue Growth (this year): -39.1% Revenue Growth (next year): 46.35%

TSVT Daily Stock ML Predictions

Stock Insider Trading Activity of 2seventy bio Inc. (TSVT)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Eatwell Victoria TSVT Chief Financial Officer Jun 3 '24 Sell $4.18 1,167 $4,880.74 95,480 SEC Form 4
Snow Jessica TSVT See Remarks Jun 3 '24 Sell $4.18 649 $2,714.31 55,622 SEC Form 4
Snow Jessica TSVT See Remarks May 3 '24 Sell $4.91 15 $73.65 56,271 SEC Form 4
Casdin Capital, LLC TSVT Director Mar 26 '24 Buy $5.10 40,000 $203,992.00 2,000,000 SEC Form 4
Casdin Capital, LLC TSVT Director Mar 21 '24 Buy $4.90 300,000 $1,470,990.00 1,482,623 SEC Form 4
Casdin Capital, LLC TSVT Director Mar 21 '24 Buy $5.12 147,377 $754,069.16 1,630,000 SEC Form 4
Casdin Capital, LLC TSVT Director Mar 21 '24 Buy $5.07 330,000 $1,673,991.00 1,960,000 SEC Form 4
Baird William D III TSVT Chief Operating Officer Jan 5 '24 Sell $3.75 1,380 $5,179.97 161,335 SEC Form 4
Gregory Philip D TSVT Chief Scientific Officer Jan 5 '24 Sell $3.75 795 $2,984.11 230,842 SEC Form 4
Leschly Nick TSVT President and CEO Jan 5 '24 Sell $3.75 1,554 $5,833.09 1,085,476 SEC Form 4
Gregory Philip D TSVT Chief Scientific Officer Jan 3 '24 Sell $3.87 25,613 $99,083.89 231,637 SEC Form 4
Leschly Nick TSVT President and CEO Jan 3 '24 Sell $3.87 72,312 $279,738.97 1,087,030 SEC Form 4

Share on Social Networks: